[1]
Kind, B. et al. 2025. Treatment of Moderate-to-severe Atopic Dermatitis with Upadacitinib: Results from an Interim Analysis of the TREATgermany Registry. Acta Dermato-Venereologica. 105, (May 2025), adv42206. DOI:https://doi.org/10.2340/actadv.v105.42206.